Skip to main content
Top
Published in: World Journal of Surgery 6/2010

01-06-2010

Normalization of 2-Week Postoperative Parathyroid Hormone Values in Patients with Primary Hyperparathyroidism: Four-Gland Exploration Compared to Focused-Approach Surgery

Authors: Peter J. Mazzaglia, Mira Milas, Eren Berber, Alan Siperstein, Jack M. Monchik

Published in: World Journal of Surgery | Issue 6/2010

Login to get access

Abstract

Background

Elevation of parathyroid hormone (PTH) levels is commonly seen in patients with primary hyperparathyroidism (PHPT) who have undergone parathyroidectomy. This study evaluates differences in 2-week postoperative PTH levels in patients having focused-approach surgery versus four-gland exploration.

Methods

Over 6 years, patients at Rhode Island Hospital (RIH) and the Cleveland Clinic (CCF) who had PHPT and underwent localization studies suggestive of single adenoma were analyzed. At RIH patients underwent focused-approach surgery, and at CCF routine four-gland exploration was performed. Postoperative calcium supplementation was routine at RIH and selective at CCF.

Results

There were 308 patients at RIH and 370 at CCF. They were similar in age (59.2 ± 13.0 years at RIH and 60.4 ± 12.9 years at CCF), and sex (76.9 and 80.0% female at RIH and CCF, respectively). The mean preoperative serum calcium measured 10.9 ± 0.7 mg/dl at RIH and 11.1 ± 0.7 mg/dl at CCF (P < 0.001). Preoperative PTH values were similar, measuring 143.8 ± 104.8 pg/ml in the focused-approach group (RIH) and 157.6 ± 150.3 pg/ml in the four-gland exploration group (CCF). Preoperative 25-hydroxyvitamin D (vitamin D-25) levels were 24.1 ± 12.0 ng/ml at RIH and 27.4 ± 10.6 ng/ml at CCF; and the prevalence of vitamin D-25 deficiency (level <20 ng/ml) was 43.9% at RIH and 27% at CCF (P = 0.017). The proportion of patients whose intraoperative PTH value dropped by ≥50% prior to completion of surgery was 95.0% at RIH and 95.5% at CCF. The total gland weight resected per patient was 942 mg at RIH versus 1,394 mg at CCF (P = 0.003). The 2-week postoperative serum PTH was >65 pg/ml in 18.8% at RIH and in 38.7% at CCF (P < 0.001). The 2-week postoperative serum calcium values dropped to 9.2 ± 0.6 mg/dl at RIH and to 9.5 ± 0.8 mg/dl at CCF (P < 0.001). The incidence of multigland disease was 5.8% at RIH and 21.9% at CCF (P ≤ 0.001).

Conclusions

Among patients with PHPT who underwent a localizing study indicating unilateral disease, a significant proportion had eucalcemic PTH elevation 2 weeks after parathyroidectomy. The elevation was more frequent in the four-gland exploration group and correlated most strongly with greater adenoma mass.
Literature
1.
go back to reference Wermers RA, Khosla S, Atkinson EJ et al (1997) The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965–1992. Ann Intern Med 126:433–440PubMed Wermers RA, Khosla S, Atkinson EJ et al (1997) The rise and fall of primary hyperparathyroidism: a population-based study in Rochester, Minnesota, 1965–1992. Ann Intern Med 126:433–440PubMed
2.
go back to reference DeLellis RA, Mazzaglia P, Mangray S (2008) Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med 132:1251–1262PubMed DeLellis RA, Mazzaglia P, Mangray S (2008) Primary hyperparathyroidism: a current perspective. Arch Pathol Lab Med 132:1251–1262PubMed
3.
go back to reference Mazzaglia PJ, Berber E, Kovach A et al (2008) The changing presentation of hyperparathyroidism over 3 decades. Arch Surg 143:260–266CrossRefPubMed Mazzaglia PJ, Berber E, Kovach A et al (2008) The changing presentation of hyperparathyroidism over 3 decades. Arch Surg 143:260–266CrossRefPubMed
4.
go back to reference Pasieka JL, Parsons LL (1998) Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 22:513–518 (discussion 518–519)CrossRefPubMed Pasieka JL, Parsons LL (1998) Prospective surgical outcome study of relief of symptoms following surgery in patients with primary hyperparathyroidism. World J Surg 22:513–518 (discussion 518–519)CrossRefPubMed
5.
go back to reference Chan AK, Duh QY, Katz MH et al (1995) Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy: a case-control study. Ann Surg 222:402–412 (discussion 412–414)CrossRefPubMed Chan AK, Duh QY, Katz MH et al (1995) Clinical manifestations of primary hyperparathyroidism before and after parathyroidectomy: a case-control study. Ann Surg 222:402–412 (discussion 412–414)CrossRefPubMed
6.
go back to reference Siperstein AE, Shen W, Chan AK et al (1992) Normocalcemic hyperparathyroidism: biochemical and symptom profiles before and after surgery. Arch Surg 127:1156–1157 (discussion 1161–1163) Siperstein AE, Shen W, Chan AK et al (1992) Normocalcemic hyperparathyroidism: biochemical and symptom profiles before and after surgery. Arch Surg 127:1156–1157 (discussion 1161–1163)
7.
go back to reference Irvin GL III, Dembrow VD, Prudhomme DL (1991) Operative monitoring of parathyroid gland hyperfunction. Am J Surg 162:299–302CrossRefPubMed Irvin GL III, Dembrow VD, Prudhomme DL (1991) Operative monitoring of parathyroid gland hyperfunction. Am J Surg 162:299–302CrossRefPubMed
8.
go back to reference Siperstein A, Berber E, Mackey R et al (2004) Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery 136:872–880CrossRefPubMed Siperstein A, Berber E, Mackey R et al (2004) Prospective evaluation of sestamibi scan, ultrasonography, and rapid PTH to predict the success of limited exploration for sporadic primary hyperparathyroidism. Surgery 136:872–880CrossRefPubMed
9.
go back to reference Irvin GL III, Carneiro DM, Solorzano CC (2004) Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg 239:704–708 (discussion 708–711)CrossRefPubMed Irvin GL III, Carneiro DM, Solorzano CC (2004) Progress in the operative management of sporadic primary hyperparathyroidism over 34 years. Ann Surg 239:704–708 (discussion 708–711)CrossRefPubMed
10.
go back to reference Udelsman R (2002) Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 235:665–670 (discussion 670–672)CrossRefPubMed Udelsman R (2002) Six hundred fifty-six consecutive explorations for primary hyperparathyroidism. Ann Surg 235:665–670 (discussion 670–672)CrossRefPubMed
11.
go back to reference Grant CS, Thompson G, Farley D et al (2005) Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 140:472–478 (discussion 478–479)CrossRefPubMed Grant CS, Thompson G, Farley D et al (2005) Primary hyperparathyroidism surgical management since the introduction of minimally invasive parathyroidectomy: Mayo Clinic experience. Arch Surg 140:472–478 (discussion 478–479)CrossRefPubMed
12.
go back to reference Van Heerden JA, Grant CS (1991) Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg 15:688–692CrossRefPubMed Van Heerden JA, Grant CS (1991) Surgical treatment of primary hyperparathyroidism: an institutional perspective. World J Surg 15:688–692CrossRefPubMed
13.
go back to reference Kaplan EL, Yashiro T, Salti G (1992) Primary hyperparathyroidism in the 1990s: choice of surgical procedures for this disease. Ann Surg 215:300–317CrossRefPubMed Kaplan EL, Yashiro T, Salti G (1992) Primary hyperparathyroidism in the 1990s: choice of surgical procedures for this disease. Ann Surg 215:300–317CrossRefPubMed
14.
go back to reference Carneiro DM, Solorzano CC, Irvin GL III (2004) Recurrent disease after limited parathyroidectomy for sporadic primary hyperparathyroidism. J Am Coll Surg 199:849–853 (discussion 853–855)CrossRefPubMed Carneiro DM, Solorzano CC, Irvin GL III (2004) Recurrent disease after limited parathyroidectomy for sporadic primary hyperparathyroidism. J Am Coll Surg 199:849–853 (discussion 853–855)CrossRefPubMed
15.
go back to reference Beyer TD, Solorzano CC, Prinz RA et al (2007) Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism. Surgery 141:777–783CrossRefPubMed Beyer TD, Solorzano CC, Prinz RA et al (2007) Oral vitamin D supplementation reduces the incidence of eucalcemic PTH elevation after surgery for primary hyperparathyroidism. Surgery 141:777–783CrossRefPubMed
16.
go back to reference Duh QY, Arnaud CD, Levin KE et al (1986) Parathyroid hormone: before and after parathyroidectomy. Surgery 100:1021–1031PubMed Duh QY, Arnaud CD, Levin KE et al (1986) Parathyroid hormone: before and after parathyroidectomy. Surgery 100:1021–1031PubMed
17.
go back to reference Irvin GL III, Newell DJ, Morgan SD (1987) Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism. Surgery 102:898–902PubMed Irvin GL III, Newell DJ, Morgan SD (1987) Parathyroid metabolism after operative treatment of hypercalcemic (primary) hyperparathyroidism. Surgery 102:898–902PubMed
18.
go back to reference Bergenfelz A, Valdemarsson S, Tibblin S (1996) Persistent elevated serum levels of intact parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of detrimental effects of severe parathyroid disease. Surgery 119:624–633CrossRefPubMed Bergenfelz A, Valdemarsson S, Tibblin S (1996) Persistent elevated serum levels of intact parathyroid hormone after operation for sporadic parathyroid adenoma: evidence of detrimental effects of severe parathyroid disease. Surgery 119:624–633CrossRefPubMed
19.
go back to reference Yen TW, Wilson SD, Krzywda EA et al (2006) The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism. Surgery 140:665–672 (discussion 672–674)CrossRefPubMed Yen TW, Wilson SD, Krzywda EA et al (2006) The role of parathyroid hormone measurements after surgery for primary hyperparathyroidism. Surgery 140:665–672 (discussion 672–674)CrossRefPubMed
20.
go back to reference Carty SE, Roberts MM, Virji MA et al (2002) Elevated serum parathormone level after “concise parathyroidectomy” for primary sporadic hyperparathyroidism. Surgery 132:1086–1092 (discussion 1092–1093)CrossRefPubMed Carty SE, Roberts MM, Virji MA et al (2002) Elevated serum parathormone level after “concise parathyroidectomy” for primary sporadic hyperparathyroidism. Surgery 132:1086–1092 (discussion 1092–1093)CrossRefPubMed
21.
go back to reference Stewart ZA, Blackford A, Somervell H et al (2005) 25-Hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy. Surgery 138:1018–1025 (discussion 1025–1026)CrossRefPubMed Stewart ZA, Blackford A, Somervell H et al (2005) 25-Hydroxyvitamin D deficiency is a risk factor for symptoms of postoperative hypocalcemia and secondary hyperparathyroidism after minimally invasive parathyroidectomy. Surgery 138:1018–1025 (discussion 1025–1026)CrossRefPubMed
22.
go back to reference Denizot A, Pucini M, Chagnaud C et al (2001) Normocalcemia with elevated parathyroid hormone levels after surgical treatment of primary hyperparathyroidism. Am J Surg 182:15–19CrossRefPubMed Denizot A, Pucini M, Chagnaud C et al (2001) Normocalcemia with elevated parathyroid hormone levels after surgical treatment of primary hyperparathyroidism. Am J Surg 182:15–19CrossRefPubMed
23.
go back to reference Nordenstrom E, Westerdahl J, Isaksson A et al (2003) Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity. World J Surg 27:212–215PubMed Nordenstrom E, Westerdahl J, Isaksson A et al (2003) Patients with elevated serum parathyroid hormone levels after parathyroidectomy: showing signs of decreased peripheral parathyroid hormone sensitivity. World J Surg 27:212–215PubMed
24.
go back to reference Picton ML, Moore PR, Mawer EB et al (2000) Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure. Kidney Int 58:1440–1449CrossRefPubMed Picton ML, Moore PR, Mawer EB et al (2000) Down-regulation of human osteoblast PTH/PTHrP receptor mRNA in end-stage renal failure. Kidney Int 58:1440–1449CrossRefPubMed
25.
go back to reference Yamashita H, Noguchi S, Moriyama T et al (2005) Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism: importance of decreased renal parathyroid hormone sensitivity. Surgery 137:419–425CrossRefPubMed Yamashita H, Noguchi S, Moriyama T et al (2005) Reelevation of parathyroid hormone level after parathyroidectomy in patients with primary hyperparathyroidism: importance of decreased renal parathyroid hormone sensitivity. Surgery 137:419–425CrossRefPubMed
26.
go back to reference Mittendorf EA, McHenry CR (2002) Persistent parathyroid hormone elevation following curative parathyroidectomy for primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg 128:275–279PubMed Mittendorf EA, McHenry CR (2002) Persistent parathyroid hormone elevation following curative parathyroidectomy for primary hyperparathyroidism. Arch Otolaryngol Head Neck Surg 128:275–279PubMed
27.
go back to reference Mittendorf EA, Merlino JI, McHenry CR (2004) Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg 70:114–119 (discussion 119–120)PubMed Mittendorf EA, Merlino JI, McHenry CR (2004) Post-parathyroidectomy hypocalcemia: incidence, risk factors, and management. Am Surg 70:114–119 (discussion 119–120)PubMed
28.
go back to reference Westerdahl J, Lindblom P, Valdemarsson S et al (2000) Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism. Arch Surg 135:142–147CrossRefPubMed Westerdahl J, Lindblom P, Valdemarsson S et al (2000) Risk factors for postoperative hypocalcemia after surgery for primary hyperparathyroidism. Arch Surg 135:142–147CrossRefPubMed
29.
go back to reference Westerdahl J, Valdemarsson S, Lindblom P et al (2000) Postoperative elevated serum levels of intact parathyroid hormone after surgery for parathyroid adenoma: sign of bone remineralization and decreased calcium absorption. World J Surg 24:1323–1329CrossRefPubMed Westerdahl J, Valdemarsson S, Lindblom P et al (2000) Postoperative elevated serum levels of intact parathyroid hormone after surgery for parathyroid adenoma: sign of bone remineralization and decreased calcium absorption. World J Surg 24:1323–1329CrossRefPubMed
30.
go back to reference Harvey A, Barbosa-Hernandez G, Walks N, et al (2008) Parathyroid tumor burden is a critical mass of parathyroid tissue necessary for manifestations of primary hyperparathyroidism. Soc Surg Oncol Harvey A, Barbosa-Hernandez G, Walks N, et al (2008) Parathyroid tumor burden is a critical mass of parathyroid tissue necessary for manifestations of primary hyperparathyroidism. Soc Surg Oncol
31.
go back to reference Bergenfelz A, Lindblom P, Tibblin S et al (2002) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 236:543–551CrossRefPubMed Bergenfelz A, Lindblom P, Tibblin S et al (2002) Unilateral versus bilateral neck exploration for primary hyperparathyroidism: a prospective randomized controlled trial. Ann Surg 236:543–551CrossRefPubMed
32.
go back to reference Siperstein A, Berber E, Barbosa GF et al (2008) Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg 248:420–428PubMed Siperstein A, Berber E, Barbosa GF et al (2008) Predicting the success of limited exploration for primary hyperparathyroidism using ultrasound, sestamibi, and intraoperative parathyroid hormone: analysis of 1158 cases. Ann Surg 248:420–428PubMed
Metadata
Title
Normalization of 2-Week Postoperative Parathyroid Hormone Values in Patients with Primary Hyperparathyroidism: Four-Gland Exploration Compared to Focused-Approach Surgery
Authors
Peter J. Mazzaglia
Mira Milas
Eren Berber
Alan Siperstein
Jack M. Monchik
Publication date
01-06-2010
Publisher
Springer-Verlag
Published in
World Journal of Surgery / Issue 6/2010
Print ISSN: 0364-2313
Electronic ISSN: 1432-2323
DOI
https://doi.org/10.1007/s00268-010-0557-6

Other articles of this Issue 6/2010

World Journal of Surgery 6/2010 Go to the issue